Dr. Everett Meyer, MD
Claim this profileStanford University
Studies Acute Lymphoblastic Leukemia
Studies Leukemia
11 reported clinical trials
23 drugs studied
Area of expertise
1Acute Lymphoblastic Leukemia
CD19 positive
CD22 negative
CD22 positive
2Leukemia
HLA-A positive
HLA-A negative
HLA positive
Affiliated Hospitals
Clinical Trials Everett Meyer, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
Hematopoietic Cell Transplantation
for Immune Tolerance in Kidney Transplant Recipients
The study will determine whether patients with functioning Human Leukocyte Antigen (HLA) matched kidney transplants for at least one year and who want to discontinue immunosuppressive drugs can be treated with Total Lymphoid Irradiation (TLI) and rabbit Anti-Thymocyte Globulin (rATG) and an HLA matched donor hematopoietic progenitor cell infusion such that their drugs are successfully withdrawn while maintaining normal renal function.
Recruiting1 award Phase 12 criteria
More about Everett Meyer, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Everett Meyer, MD has experience with
- Cyclophosphamide
- Orca-T
- Fludarabine
- Standard-of-Care
- Donor Regulatory T Cells
- CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells
Breakdown of trials Everett Meyer, MD has run
Acute Lymphoblastic Leukemia
Leukemia
Acute Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Everett Meyer, MD specialize in?
Everett Meyer, MD focuses on Acute Lymphoblastic Leukemia and Leukemia. In particular, much of their work with Acute Lymphoblastic Leukemia has involved CD19 positive patients, or patients who are CD22 negative.
Is Everett Meyer, MD currently recruiting for clinical trials?
Yes, Everett Meyer, MD is currently recruiting for 5 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Everett Meyer, MD has studied deeply?
Yes, Everett Meyer, MD has studied treatments such as Cyclophosphamide, Orca-T, Fludarabine.
What is the best way to schedule an appointment with Everett Meyer, MD?
Apply for one of the trials that Everett Meyer, MD is conducting.
What is the office address of Everett Meyer, MD?
The office of Everett Meyer, MD is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.